iPSC-derived hindbrain organoids to evaluate escitalopram oxalate treatment responses targeting neuropsychiatric symptoms in Alzheimer’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
iPSC-derived hindbrain organoids to evaluate escitalopram oxalate treatment responses targeting neuropsychiatric symptoms in Alzheimer’s disease ; day:5 ; month:6 ; year:2024 ; pages:1-9
Molecular psychiatry ; (5.6.2024), 1-9
- Creator
-
Zivko, Cristina
Sagar, Ram
Xydia, Ariadni
Lopez-Montes, Alejandro
Mintzer, Jacobo
Rosenberg, Paul B.
Shade, David M.
Porsteinsson, Anton P.
Lyketsos, Constantine G.
Mahairaki, Vasiliki
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41380-024-02629-y
- URN
-
urn:nbn:de:101:1-2408131154393.087779009573
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zivko, Cristina
- Sagar, Ram
- Xydia, Ariadni
- Lopez-Montes, Alejandro
- Mintzer, Jacobo
- Rosenberg, Paul B.
- Shade, David M.
- Porsteinsson, Anton P.
- Lyketsos, Constantine G.
- Mahairaki, Vasiliki
- SpringerLink (Online service)
Other Objects (12)
Network analysis of neuropsychiatric symptoms in Alzheimer’s disease
Causal influences of neuropsychiatric disorders on Alzheimer’s disease
Associations between neuropsychiatric symptoms and incident Alzheimer’s dementia in men versus women
Persisting neuropsychiatric symptoms, Alzheimer’s disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate
Monoamine alterations in Alzheimer’s disease and their implications in comorbid neuropsychiatric symptoms
Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a meta-analysis
Brain Lipids and Lipid Droplet Dysregulation in Alzheimer’s Disease and Neuropsychiatric Disorders
Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer’s disease
Limitations of the human iPSC-derived neuron model for early-onset Alzheimer’s disease
Human tau-overexpressing mice recapitulate brainstem involvement and neuropsychiatric features of early Alzheimer’s disease
APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer’s disease patient iPSC-derived cerebral organoids
Analysis of Neuropsychiatric Symptoms in Patients with Alzheimer’s Disease Using Quantitative EEG and sLORETA
Network analysis of neuropsychiatric symptoms in Alzheimer’s disease
Causal influences of neuropsychiatric disorders on Alzheimer’s disease
Associations between neuropsychiatric symptoms and incident Alzheimer’s dementia in men versus women
Persisting neuropsychiatric symptoms, Alzheimer’s disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate
Monoamine alterations in Alzheimer’s disease and their implications in comorbid neuropsychiatric symptoms
Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a meta-analysis
Brain Lipids and Lipid Droplet Dysregulation in Alzheimer’s Disease and Neuropsychiatric Disorders
Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer’s disease
Limitations of the human iPSC-derived neuron model for early-onset Alzheimer’s disease
Human tau-overexpressing mice recapitulate brainstem involvement and neuropsychiatric features of early Alzheimer’s disease
APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer’s disease patient iPSC-derived cerebral organoids
Analysis of Neuropsychiatric Symptoms in Patients with Alzheimer’s Disease Using Quantitative EEG and sLORETA
Network analysis of neuropsychiatric symptoms in Alzheimer’s disease
Causal influences of neuropsychiatric disorders on Alzheimer’s disease
Associations between neuropsychiatric symptoms and incident Alzheimer’s dementia in men versus women
Persisting neuropsychiatric symptoms, Alzheimer’s disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate
Monoamine alterations in Alzheimer’s disease and their implications in comorbid neuropsychiatric symptoms
Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a meta-analysis
Brain Lipids and Lipid Droplet Dysregulation in Alzheimer’s Disease and Neuropsychiatric Disorders
Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer’s disease
Limitations of the human iPSC-derived neuron model for early-onset Alzheimer’s disease
Human tau-overexpressing mice recapitulate brainstem involvement and neuropsychiatric features of early Alzheimer’s disease
APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer’s disease patient iPSC-derived cerebral organoids